Physician profile
Heather E Smith
NPI 1255814935
$692.92
in general payments reported to CMS, 2019-2025
8 companies · $38.42 in 2025
The $38.42 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $50.06 · 2024: $604 · 2025: $38.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $692.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $202.58 | 2024 | Stelara |
| Janssen Biotech, INC. | $176.33 | 2023-2024 | Stelara, Tremfya |
| Novartis Pharmaceuticals Corporation | $94.46 | 2023-2024 | |
| Amgen INC. | $62.00 | 2024-2025 | Krystexxa |
| Lundbeck LLC | $58.60 | 2024 | Vyepti |
| Eisai INC. | $44.79 | 2024 | |
| Argenx US, INC. | $32.51 | 2024-2025 | Vyvgart Hytrulo |
| Alnylam Pharmaceuticals INC. | $21.65 | 2024 | Onpattro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.